Vision Associates Inc - Medicare Optometrist in Greenville, RI

Vision Associates Inc is a medicare enrolled "Optometrist" provider in Greenville, Rhode Island. Their current practice location is 12 Smith Ave, Greenville, Rhode Island. You can reach out to their office (for appointments etc.) via phone at (401) 949-1616.

Vision Associates Inc is licensed to practice in * (Not Available) (license number ) and it also participates in the medicare program. Vision Associates Inc is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1346296209.

Contact Information

Vision Associates Inc
12 Smith Ave,
Greenville, RI 02828-1720
(401) 949-1616
(888) 965-9985



Healthcare Provider's Profile

Full NameVision Associates Inc
TypeFacility
SpecialityOptometrist
Location12 Smith Ave, Greenville, Rhode Island
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1346296209
  • Provider Enumeration Date: 05/25/2006
  • Last Update Date: 05/14/2013
  Medicare PECOS Information:
  • PECOS PAC ID: 5294890695
  • Enrollment ID: O20090219000084

Medical Identifiers

Medical identifiers for Vision Associates Inc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1346296209NPI-NPPES
VA00267MedicaidRI

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Vision Associates Inc acts as a billing entity for following providers:
Provider NameDavid J Jennings
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1376547851
PECOS PAC ID: 9234113002
Enrollment ID: I20070518000523

News Archive

Dyadic third quarter total revenue decreases to $2.0 million

Dyadic International, Inc., a global biotechnology company focused on the discovery, development, manufacture and sale of specialty enzyme and protein products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, today announced financial results for the third quarter ended September 30, 2010.

'Sharing Age' campaign receives EC grant to encourage health ageing

The European Commission has awarded €1 million to fund a campaign promoting health ageing 'Sharing Age' coordinated by Dr Sabina Brennan of the Trinity College Institute of Neuroscience.

WSU researchers study how sleep loss affects critical aspects of decision making in real-world situations

The difference between life and death in the operating room, on the battlefield or during a police shootout often comes down to the ability to adapt to the unexpected. Sleep deprivation may make it difficult to do so, according to a Washington State University study published this month in the journal Sleep.

Life Technologies forms GIBCO Cell Therapy Systems

Life Technologies Corporation today announced the formation of GIBCO® Cell Therapy Systems (CTS™), which will offer the life science industry's widest array of products to support cell therapy applications, including regenerative medicine. Specifically designed to help cell therapy practitioners accelerate the transition from research to clinical applications, the product portfolio will include a broad and deep offering of Invitrogen devices and reagents.

DCR representatives to present health-related quality posters at NKF's 2015 Spring Clinical Meeting

DaVita Clinical Research, a specialty contract research organization with services spanning the full spectrum of drug and device development and subsidiary of DaVita HealthCare Partners Inc., today announced that company representatives will present health-related quality posters at National Kidney Foundation's 2015 Spring Clinical Meeting, which takes place March 25-29, 2015 in Dallas.

Read more Medical News

› Verified 2 days ago

Provider NameEric J Hall
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1396798971
PECOS PAC ID: 8729143128
Enrollment ID: I20120411000094

News Archive

Dyadic third quarter total revenue decreases to $2.0 million

Dyadic International, Inc., a global biotechnology company focused on the discovery, development, manufacture and sale of specialty enzyme and protein products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, today announced financial results for the third quarter ended September 30, 2010.

'Sharing Age' campaign receives EC grant to encourage health ageing

The European Commission has awarded €1 million to fund a campaign promoting health ageing 'Sharing Age' coordinated by Dr Sabina Brennan of the Trinity College Institute of Neuroscience.

WSU researchers study how sleep loss affects critical aspects of decision making in real-world situations

The difference between life and death in the operating room, on the battlefield or during a police shootout often comes down to the ability to adapt to the unexpected. Sleep deprivation may make it difficult to do so, according to a Washington State University study published this month in the journal Sleep.

Life Technologies forms GIBCO Cell Therapy Systems

Life Technologies Corporation today announced the formation of GIBCO® Cell Therapy Systems (CTS™), which will offer the life science industry's widest array of products to support cell therapy applications, including regenerative medicine. Specifically designed to help cell therapy practitioners accelerate the transition from research to clinical applications, the product portfolio will include a broad and deep offering of Invitrogen devices and reagents.

DCR representatives to present health-related quality posters at NKF's 2015 Spring Clinical Meeting

DaVita Clinical Research, a specialty contract research organization with services spanning the full spectrum of drug and device development and subsidiary of DaVita HealthCare Partners Inc., today announced that company representatives will present health-related quality posters at National Kidney Foundation's 2015 Spring Clinical Meeting, which takes place March 25-29, 2015 in Dallas.

Read more Medical News

› Verified 2 days ago

Provider NameJoseph L Rowey
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1003862962
PECOS PAC ID: 5092870493
Enrollment ID: I20120411000123

News Archive

Dyadic third quarter total revenue decreases to $2.0 million

Dyadic International, Inc., a global biotechnology company focused on the discovery, development, manufacture and sale of specialty enzyme and protein products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, today announced financial results for the third quarter ended September 30, 2010.

'Sharing Age' campaign receives EC grant to encourage health ageing

The European Commission has awarded €1 million to fund a campaign promoting health ageing 'Sharing Age' coordinated by Dr Sabina Brennan of the Trinity College Institute of Neuroscience.

WSU researchers study how sleep loss affects critical aspects of decision making in real-world situations

The difference between life and death in the operating room, on the battlefield or during a police shootout often comes down to the ability to adapt to the unexpected. Sleep deprivation may make it difficult to do so, according to a Washington State University study published this month in the journal Sleep.

Life Technologies forms GIBCO Cell Therapy Systems

Life Technologies Corporation today announced the formation of GIBCO® Cell Therapy Systems (CTS™), which will offer the life science industry's widest array of products to support cell therapy applications, including regenerative medicine. Specifically designed to help cell therapy practitioners accelerate the transition from research to clinical applications, the product portfolio will include a broad and deep offering of Invitrogen devices and reagents.

DCR representatives to present health-related quality posters at NKF's 2015 Spring Clinical Meeting

DaVita Clinical Research, a specialty contract research organization with services spanning the full spectrum of drug and device development and subsidiary of DaVita HealthCare Partners Inc., today announced that company representatives will present health-related quality posters at National Kidney Foundation's 2015 Spring Clinical Meeting, which takes place March 25-29, 2015 in Dallas.

Read more Medical News

› Verified 2 days ago

Provider NameRonald Hall
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1588618433
PECOS PAC ID: 3274698675
Enrollment ID: I20120820000232

News Archive

Dyadic third quarter total revenue decreases to $2.0 million

Dyadic International, Inc., a global biotechnology company focused on the discovery, development, manufacture and sale of specialty enzyme and protein products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, today announced financial results for the third quarter ended September 30, 2010.

'Sharing Age' campaign receives EC grant to encourage health ageing

The European Commission has awarded €1 million to fund a campaign promoting health ageing 'Sharing Age' coordinated by Dr Sabina Brennan of the Trinity College Institute of Neuroscience.

WSU researchers study how sleep loss affects critical aspects of decision making in real-world situations

The difference between life and death in the operating room, on the battlefield or during a police shootout often comes down to the ability to adapt to the unexpected. Sleep deprivation may make it difficult to do so, according to a Washington State University study published this month in the journal Sleep.

Life Technologies forms GIBCO Cell Therapy Systems

Life Technologies Corporation today announced the formation of GIBCO® Cell Therapy Systems (CTS™), which will offer the life science industry's widest array of products to support cell therapy applications, including regenerative medicine. Specifically designed to help cell therapy practitioners accelerate the transition from research to clinical applications, the product portfolio will include a broad and deep offering of Invitrogen devices and reagents.

DCR representatives to present health-related quality posters at NKF's 2015 Spring Clinical Meeting

DaVita Clinical Research, a specialty contract research organization with services spanning the full spectrum of drug and device development and subsidiary of DaVita HealthCare Partners Inc., today announced that company representatives will present health-related quality posters at National Kidney Foundation's 2015 Spring Clinical Meeting, which takes place March 25-29, 2015 in Dallas.

Read more Medical News

› Verified 2 days ago

Provider NameDena Carl Hall
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1689627341
PECOS PAC ID: 2466517867
Enrollment ID: I20120921000010

News Archive

Dyadic third quarter total revenue decreases to $2.0 million

Dyadic International, Inc., a global biotechnology company focused on the discovery, development, manufacture and sale of specialty enzyme and protein products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, today announced financial results for the third quarter ended September 30, 2010.

'Sharing Age' campaign receives EC grant to encourage health ageing

The European Commission has awarded €1 million to fund a campaign promoting health ageing 'Sharing Age' coordinated by Dr Sabina Brennan of the Trinity College Institute of Neuroscience.

WSU researchers study how sleep loss affects critical aspects of decision making in real-world situations

The difference between life and death in the operating room, on the battlefield or during a police shootout often comes down to the ability to adapt to the unexpected. Sleep deprivation may make it difficult to do so, according to a Washington State University study published this month in the journal Sleep.

Life Technologies forms GIBCO Cell Therapy Systems

Life Technologies Corporation today announced the formation of GIBCO® Cell Therapy Systems (CTS™), which will offer the life science industry's widest array of products to support cell therapy applications, including regenerative medicine. Specifically designed to help cell therapy practitioners accelerate the transition from research to clinical applications, the product portfolio will include a broad and deep offering of Invitrogen devices and reagents.

DCR representatives to present health-related quality posters at NKF's 2015 Spring Clinical Meeting

DaVita Clinical Research, a specialty contract research organization with services spanning the full spectrum of drug and device development and subsidiary of DaVita HealthCare Partners Inc., today announced that company representatives will present health-related quality posters at National Kidney Foundation's 2015 Spring Clinical Meeting, which takes place March 25-29, 2015 in Dallas.

Read more Medical News

› Verified 2 days ago

Provider NameNoelle Tiberi
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1447827142
PECOS PAC ID: 4789085663
Enrollment ID: I20210629003426

News Archive

Dyadic third quarter total revenue decreases to $2.0 million

Dyadic International, Inc., a global biotechnology company focused on the discovery, development, manufacture and sale of specialty enzyme and protein products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, today announced financial results for the third quarter ended September 30, 2010.

'Sharing Age' campaign receives EC grant to encourage health ageing

The European Commission has awarded €1 million to fund a campaign promoting health ageing 'Sharing Age' coordinated by Dr Sabina Brennan of the Trinity College Institute of Neuroscience.

WSU researchers study how sleep loss affects critical aspects of decision making in real-world situations

The difference between life and death in the operating room, on the battlefield or during a police shootout often comes down to the ability to adapt to the unexpected. Sleep deprivation may make it difficult to do so, according to a Washington State University study published this month in the journal Sleep.

Life Technologies forms GIBCO Cell Therapy Systems

Life Technologies Corporation today announced the formation of GIBCO® Cell Therapy Systems (CTS™), which will offer the life science industry's widest array of products to support cell therapy applications, including regenerative medicine. Specifically designed to help cell therapy practitioners accelerate the transition from research to clinical applications, the product portfolio will include a broad and deep offering of Invitrogen devices and reagents.

DCR representatives to present health-related quality posters at NKF's 2015 Spring Clinical Meeting

DaVita Clinical Research, a specialty contract research organization with services spanning the full spectrum of drug and device development and subsidiary of DaVita HealthCare Partners Inc., today announced that company representatives will present health-related quality posters at National Kidney Foundation's 2015 Spring Clinical Meeting, which takes place March 25-29, 2015 in Dallas.

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Vision Associates Inc is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Vision Associates Inc
12 Smith Ave,
Greenville, RI 02828-1720

Ph: (401) 949-1616
Vision Associates Inc
12 Smith Ave,
Greenville, RI 02828-1720

Ph: (401) 949-1616

News Archive

Dyadic third quarter total revenue decreases to $2.0 million

Dyadic International, Inc., a global biotechnology company focused on the discovery, development, manufacture and sale of specialty enzyme and protein products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, today announced financial results for the third quarter ended September 30, 2010.

'Sharing Age' campaign receives EC grant to encourage health ageing

The European Commission has awarded €1 million to fund a campaign promoting health ageing 'Sharing Age' coordinated by Dr Sabina Brennan of the Trinity College Institute of Neuroscience.

WSU researchers study how sleep loss affects critical aspects of decision making in real-world situations

The difference between life and death in the operating room, on the battlefield or during a police shootout often comes down to the ability to adapt to the unexpected. Sleep deprivation may make it difficult to do so, according to a Washington State University study published this month in the journal Sleep.

Life Technologies forms GIBCO Cell Therapy Systems

Life Technologies Corporation today announced the formation of GIBCO® Cell Therapy Systems (CTS™), which will offer the life science industry's widest array of products to support cell therapy applications, including regenerative medicine. Specifically designed to help cell therapy practitioners accelerate the transition from research to clinical applications, the product portfolio will include a broad and deep offering of Invitrogen devices and reagents.

DCR representatives to present health-related quality posters at NKF's 2015 Spring Clinical Meeting

DaVita Clinical Research, a specialty contract research organization with services spanning the full spectrum of drug and device development and subsidiary of DaVita HealthCare Partners Inc., today announced that company representatives will present health-related quality posters at National Kidney Foundation's 2015 Spring Clinical Meeting, which takes place March 25-29, 2015 in Dallas.

Read more News

› Verified 2 days ago


Optometrist in Greenville, RI

Ronald J. Hall O.d.
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 12 Smith Ave, Greenville, RI 02828
Phone: 401-949-1616    
Smithfield Eye & Optical Llc
Optometrist
Medicare: Medicare Enrolled
Practice Location: 600 Putnam Pike Ste 3, Greenville, RI 02828
Phone: 401-949-7300    
Eric J Hall, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 12 Smith Ave, Greenville, RI 02828
Phone: 401-949-1616    Fax: 401-949-4251
Noelle Tiberi,
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 12 Smith Ave, Greenville, RI 02828
Phone: 401-949-1616    Fax: 401-942-0952
Pamela S. Sheffield, O.d.
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 600 Putnam Pike Ste 3, Greenville, RI 02828
Phone: 401-949-7300    Fax: 401-949-5052
Dr. Ronald J Hall, O.D.
Optometrist
Medicare: Medicare Enrolled
Practice Location: 12 Smith Ave, Greenville, RI 02828
Phone: 401-949-1616    Fax: 401-949-4251

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.